LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma

Xiang Chen; Margaret Clement; M. John Hicks; Poonam Sarkar; M. Waleed Gaber; Tsz-Kwong Man

doi:10.1016/j.gendis.2021.12.016

您当前的位置：

首页 >

文章列表页 >

LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma

Full-length article | 更新时间：2023-08-29

- LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma
- LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma
- Genes & Diseases 2023年10卷第1期
- 作者机构：
  
  1. Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza,TX,Houston,USA,77030
  2. Texas Children's Cancer and Hematology Centers, 1102 Bates St,TX,Houston,USA,77030
  3. Department of Pathology, Baylor College of Medicine, One Baylor Plaza,TX,Houston,USA,77030
  4. Dan L. Duncan Comprehensive Cancer Center, 7200 Cambridge Street,TX,Houston,USA,77054
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2021.12.016
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-1-1，
扫描看全文
Xiang Chen, Margaret Clement, M. John Hicks, 等. LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma[J]. Genes & Diseases, 2023,10(1).

Xiang Chen, Margaret Clement, M. John Hicks, et al. LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma[J]. Genes & Diseases, 2023,10(1).
Xiang Chen, Margaret Clement, M. John Hicks, 等. LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2021.12.016.

Xiang Chen, Margaret Clement, M. John Hicks, et al. LOX upregulates FAK phosphorylation to promote metastasis in osteosarcoma[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2021.12.016.

摘要

Abstract

Osteosarcoma is a malignant bone tumor that commonly occurs in the pediatric population. Despite the use of chemotherapy and surgery

metastasis remains to be the leading cause of death in patients with osteosarcoma. We have previously reported that cytoplasmic mislocalization of p27 is associated with a poor outcome in osteosarcoma. In this study

we further show that lysyl oxidase (LOX) expression was associated with p27 mislocalization. LOX is an enigmatic molecule that acts as a tumor suppressor or a metastatic promoter; however

its role in osteosarcoma is still unclear. Hence

we performed both

in vitro

and

in vivo

analyses to dissect the role of LOX in osteosarcoma. The result of our survival analysis indicated that LOX expression significantly correlated with a poor outcome in osteosarcoma with or without controlling for the initial metastasis status (

0.05). Functionally

we found that higher LOX expression promoted osteosarcoma cell proliferation

migration

and invasiveness

in vitro

and produced a higher number of mice with pulmonary metastases in an orthotopic xenograft mouse model. Mechanistically

phospho-FAK was increased in osteosarcoma cells with high LOX expression. Our results further showed that FAK inhibition significantly reduced tumor cell proliferation and migration

in vitro

as well as LOX-mediated metastasis in mice. Together

our findings suggest that there is a novel link between p27 mislocalization and LOX expression. LOX plays a pivotal role in osteosarcoma metastasis by upregulating FAK phosphorylation. FAK inhibition may constitute a promising therapeutic strategy to reduce the development of metastasis in osteosarcoma with LOX overexpression.

关键词

Keywords

Focal adhesion kinaseLysyl oxidaseMetastasisOsteosarcoma

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA

The generation and use of animal models of osteosarcoma in cancer research

Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration

Aberrant LETM1 elevation dysregulates mitochondrial functions and energy metabolism and promotes lung metastasis in osteosarcoma

Loss of GATA6-mediated up-regulation of UTX promotes pancreatic tumorigenesis and progression